Similar Search Results

European Healthcare Policies for Controlling Drug Expenditure

Ess, Silvia M.; Schneeweiss, Sebastian; Szucs, Thomas D. - In: PharmacoEconomics 21 (2003) 2, pp. 89-103

In the last 20 years, expenditures on pharmaceuticals - as well as total health expenditures - have grown faster than the gross national product in all European countries. The aim of this paper was to review policies that European governments apply to reduce or at least slow down public...

Persistent link: https://www.econbiz.de/10005404914

NICE Methodological Guidelines and Decision Making in the National Health Service in England and Wales

Gafni, Amiram; Birch, Stephen - In: PharmacoEconomics 21 (2003) 3, pp. 149-157

The National Institute for Clinical Excellence (NICE) responds to requests by the Department of Health for guidance on the use of selected new and established technologies in the National Health Service (NHS) in England and Wales. This paper asks whether the NICE methodological guidelines help...

Persistent link: https://www.econbiz.de/10004990353

A Review of Alternative Approaches to Healthcare Resource Allocation

Petrou, Stavros; Wolstenholme, Jane - In: PharmacoEconomics 18 (2000) 1, pp. 33-43

The resources available for healthcare are limited compared with demand, if not need, and all healthcare systems, regardless of their financing and organisation, employ mechanisms to ration or prioritise finite healthcare resources. This paper reviews alternative approaches that can be used to...

Persistent link: https://www.econbiz.de/10005243137

Inhaled Fluticasone Propionate: A Pharmacoeconomic Review of its Use in the Management of Asthma

Lamb, Harriet M.; Culy, Christine R.; Faulds, Diana - In: PharmacoEconomics 18 (2000) 5, pp. 487-510

of budesonide. In children, fluticasone propionate was more cost effective per treatment success compared with inhaled …

Persistent link: https://www.econbiz.de/10005404779

Is the Childhood Asthma Questionnaire a Good Measure of Health-Related Quality of Life of Asthmatic Children in Asia?: Validation Among Paediatric Patients with Asthma in Singapore

Chong, Lee-Yee; Chay, Oh-Moh; Shu-Chuen, Li - In: PharmacoEconomics 24 (2006) 6, pp. 609-621

diseases such as asthma. However, this measure is rarely used in young children in Asia because of the difficulty of obtaining … validate a disease-specific HR-QOL questionnaire (Childhood Asthma Questionnaire [CAQ]-B) for asthmatic children aged 7 … children had no difficulty understanding and completing the questionnaire. The median time taken to complete a questionnaire …

Persistent link: https://www.econbiz.de/10005404786

Cost of Illness of Atopic Dermatitis in Children: A Societal Perspective

Kemp, Andrew S. - In: PharmacoEconomics 21 (2003) 2, pp. 105-113

decades. The family stress related to the care of children with moderate or severe atopic dermatitis is significantly greater … than that of the care of children with type 1 diabetes mellitus. The factors contributing to family stress include sleep …

Persistent link: https://www.econbiz.de/10005404824

Household-Based Costs and Benefits of Vaccinating Healthy Children in Daycare Against Influenza Virus: Results from a Pilot Study

Pisu, Maria; Meltzer, Martin I.; Hurwitz, Eugene S.; … - In: PharmacoEconomics 23 (2005) 1, pp. 55-67

Background: Vaccinating children against influenza virus may reduce infections in immunised children and household … influenza virus vaccination of daycare children on costs of respiratory illnesses of the children and their household contacts … covering the period November to April of 1996-7 and 1998-9. Children (127 in 1996-7 and 133 in 1998-9) from daycare centres in …

Persistent link: https://www.econbiz.de/10005404931

Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children: Theoretical and Methodological Considerations

Prosser, Lisa A.; Hammitt, James K.; Keren, Ron - In: PharmacoEconomics 25 (2007) 9, pp. 713-726

Valuing the health of children for cost-utility or cost-benefit analysis poses a number of additional challenges when … compared with valuing adult health. Some of these challenges relate to the inability of young children to value changes in … health directly and the potential biases associated with using proxy respondents. Other challenges arise from children not …

Persistent link: https://www.econbiz.de/10005404944

Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6-11 Years: A NICE Single Technology Appraisal

Burch, Jane; Griffin, Susan; McKenna, Claire; Walker, Simon - In: PharmacoEconomics 30 (2012) 11, pp. 991-1004

children with ≥3 exacerbations as baseline. The ERG identified a number of issues relating to the clinical effectiveness …-of-life data collected in adults for children. The ERG concluded that omalizumab appears to reduce CS exacerbations but there was … number of CSS exacerbations avoided was low, as is asthma-related mortality in children, the potential small gain in QALYs …

Persistent link: https://www.econbiz.de/10010579449

Evaluating Health-Related Quality-of-Life Studies in Paediatric Populations: Some Conceptual, Methodological and Developmental Considerations and Recent Applications

De Civita, Mirella; Regier, Dean; Alamgir, Abul H.; … - In: PharmacoEconomics 23 (2005) 7, pp. 659-685

overall QOL should be defined and measured in children. It is recommended that future studies focus on operationalising and … are still used interchangeably when comparing child and parent reports of children's HR-QOL. The Pearson correlation is a … may have occurred in the evaluation of HR-QOL. Most studies have compared HR-QOL scores of children with illness with …

Persistent link: https://www.econbiz.de/10005590322